# Ludovic Caillo

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/ludovic-caillo/

## Facts

| Field | Value |
| --- | --- |
| Citations | 1,039 |
| Field | Inflammatory Bowel Disease |
| h-index | 20 |
| i10-index | 31 |
| Last Known Institution | Université de Nîmes |
| OpenAlex ID | https://openalex.org/A5009919176 |
| ORCID iD | 0000-0002-4110-1866 |
| Works | 114 |

## Researcher papers

- [Ustekinumab for Perianal Crohn's Disease: The BioLAP Multicenter Study From the GETAID](https://scholariq.org/papers/ustekinumab-for-perianal-crohn-s-disease-the-biolap-multicenter-study-from-the/)
- [Vedolizumab Therapy is Ineffective for Primary Sclerosing Cholangitis in Patients With Inflammatory Bowel Disease: A GETAID Multicentre Cohort Study](https://scholariq.org/papers/vedolizumab-therapy-is-ineffective-for-primary-sclerosing-cholangitis-in/)
- [Early hepatocellular carcinoma detection using magnetic resonance imaging is cost-effective in high-risk patients with cirrhosis](https://scholariq.org/papers/early-hepatocellular-carcinoma-detection-using-magnetic-resonance-imaging-is/)
- [Pregnane X-receptor promotes stem cell-mediated colon cancer relapse](https://scholariq.org/papers/pregnane-x-receptor-promotes-stem-cell-mediated-colon-cancer-relapse/)
- [Comparative efficacy and safety of vedolizumab and infliximab in ulcerative colitis after failure of a first subcutaneous anti‐TNF agent: a multicentre cohort study](https://scholariq.org/papers/comparative-efficacy-and-safety-of-vedolizumab-and-infliximab-in-ulcerative/)
- [Comparative Acceptability of Therapeutic Maintenance Regimens in Patients With Inflammatory Bowel Disease: Results From the Nationwide ACCEPT2 Study](https://scholariq.org/papers/comparative-acceptability-of-therapeutic-maintenance-regimens-in-patients-with/)
- [Per-oral endoscopic myotomy with septotomy for the treatment of distal esophageal diverticula (D-POEM)](https://scholariq.org/papers/per-oral-endoscopic-myotomy-with-septotomy-for-the-treatment-of-distal/)
- [An Anti-migration Self-expandable and Removable Metal Stent for Crohn’s Disease Strictures: A Nationwide Study From GETAID and SFED](https://scholariq.org/papers/an-anti-migration-self-expandable-and-removable-metal-stent-for-crohn-s-disease/)
- [I-CARE, a European Prospective Cohort Study Assessing Safety and Effectiveness of Biologics in Inflammatory Bowel Disease](https://scholariq.org/papers/i-care-a-european-prospective-cohort-study-assessing-safety-and-effectiveness-of/)
- [Clinical guidelines for the management of inflammatory bowel disease: Update of a French national consensus](https://scholariq.org/papers/clinical-guidelines-for-the-management-of-inflammatory-bowel-disease-update-of-a/)
- [Effectiveness of endoscopic ultrasound (EUS)‐guided choledochoduodenostomy vs. EUS‐guided gallbladder drainage for jaundice in patients with malignant distal biliary obstruction after failed endoscopic retrograde cholangiopancreatography: Retrospective, multicenter study (GALLBLADEUS Study)](https://scholariq.org/papers/effectiveness-of-endoscopic-ultrasound-eus-guided-choledochoduodenostomy-vs-eus/)

## Researcher topics

- [Inflammatory Bowel Disease](https://scholariq.org/topics/inflammatory-bowel-disease/)
- [Microscopic Colitis](https://scholariq.org/topics/microscopic-colitis/)
- [Gastroesophageal reflux and treatments](https://scholariq.org/topics/gastroesophageal-reflux-and-treatments/)
- [Gastric Cancer Management and Outcomes](https://scholariq.org/topics/gastric-cancer-management-and-outcomes/)
- [Autoimmune and Inflammatory Disorders](https://scholariq.org/topics/autoimmune-and-inflammatory-disorders/)

## Researcher university

- [Université de Nîmes](https://scholariq.org/institutions/universite-de-nimes/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.